RT @HCUAmerica: @drgenomics @studyrare @ChildrensNatl 1) Guidelines for Diagnosis & Management of Cysathionine Beta Synthase https://t.co/x…
RT @HCUAmerica: @drgenomics @studyrare @ChildrensNatl 1) Guidelines for Diagnosis & Management of Cysathionine Beta Synthase https://t.co/x…
@drgenomics @studyrare @ChildrensNatl 1) Guidelines for Diagnosis & Management of Cysathionine Beta Synthase https://t.co/x2V5Q9x4YO 2) Guidelines for diagnosis & management of the cobalamin-related remethylation disorders deficiency https://t.co/
#HCUAwareness2022 #HCUFact 20: Approved treatment for #MTHFR currently only includes betaine. From the guidelines for diagnosis and treatment of Cobalamin and MTHFR: https://t.co/SWWm1mdlhs https://t.co/NvfcUKIoE5
RT @HCUAmerica: #RareDiseaseDay Fact 19: In 2017, the Guidelines for diagnosis and management of the #cobalamin -related remethylation diso…
RT @HCUAmerica: #RareDiseaseDay Fact 19: In 2017, the Guidelines for diagnosis and management of the #cobalamin -related remethylation diso…
RT @HCUAmerica: #RareDiseaseDay Fact 19: In 2017, the Guidelines for diagnosis and management of the #cobalamin -related remethylation diso…
RT @HCUAmerica: #RareDiseaseDay Fact 19: In 2017, the Guidelines for diagnosis and management of the #cobalamin -related remethylation diso…
#RareDiseaseDay Fact 19: In 2017, the Guidelines for diagnosis and management of the #cobalamin -related remethylation disorders and MTHFR deficiency were published in the @JIMD_Editors https://t.co/SWWm1mcNrU https://t.co/3KmIXd0p5t
RT @HCUAmerica: #HCUAwareness2021#HCUFact 20: Approved treatment for MTHFR currently only includes betaine. From the guidelines for diag…
#HCUAwareness2021#HCUFact 20: Approved treatment for MTHFR currently only includes betaine. From the guidelines for diagnosis and treatment of Cobalamin and MTHFR. https://t.co/SWWm1mcNrU https://t.co/9sycvVv3m6
@Fran_Tena Link to guidelines: https://t.co/deGaRQCoeC
RT @JIMD_Editors: Our themed tweets begin with 'something old' Guidelines for diagnosis and management of the cobalamin-related remethylati…
RT @JIMD_Editors: Our themed tweets begin with 'something old' Guidelines for diagnosis and management of the cobalamin-related remethylati…
RT @JIMD_Editors: Our themed tweets begin with 'something old' Guidelines for diagnosis and management of the cobalamin-related remethylati…
RT @JIMD_Editors: Our themed tweets begin with 'something old' Guidelines for diagnosis and management of the cobalamin-related remethylati…
RT @JIMD_Editors: Our themed tweets begin with 'something old' Guidelines for diagnosis and management of the cobalamin-related remethylati…
Our themed tweets begin with 'something old' Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency Martina Huemer, @AGarciaCazorla et al https://t.co/rhuu0ywe15 http
RT @HCUAmerica: #RareDiseaseDay Fact 19: In 2017, the Guidelines for diagnosis and management of the #cobalamin -related remethylation diso…
RT @HCUAmerica: #RareDiseaseDay Fact 19: In 2017, the Guidelines for diagnosis and management of the #cobalamin -related remethylation diso…
#RareDiseaseDay Fact 19: In 2017, the Guidelines for diagnosis and management of the #cobalamin -related remethylation disorders and MTHFR deficiency were published in the @JIMD_Editors https://t.co/SWWm1mcNrU https://t.co/0mJYsvx6Kn
#HCUAwareness2020#HCUFact 21: The treatment Guidelines for MTHFR are: Betaine, folonic acid or methylfolate and/or L-Methionine. Here is the a link to the guidelines for diagnosis and treatment of Cobalamin and MTHFR. https://t.co/SWWm1mcNrU https://t.c
RT @HCUAmerica: HCU Fact 19: In 2017, the Guidelines for diagnosis and management of the #cobalamin -related remethylation disorders and MT…
RT @HCUAmerica: HCU Fact 19: In 2017, the Guidelines for diagnosis and management of the #cobalamin -related remethylation disorders and MT…
@HCUAmerica Here’s an #openaccess version hosted over at our new home with @Wiley_Health https://t.co/rhuu0ywe15 @AGarciaCazorla
HCU Fact 19: In 2017, the Guidelines for diagnosis and management of the #cobalamin -related remethylation disorders and MTHFR deficiency were published in the @JIMD_Editors . Every geneticist should see these guidelines. Visit to read: https://t.co/2ynAB7
RT @JIMD_Editors: Another article from 2017’s January guideline bonanza: #openaccess Guidelines for diagnosis and management of the cobalam…
RT @JIMD_Editors: Another article from 2017’s January guideline bonanza: #openaccess Guidelines for diagnosis and management of the cobalam…
RT @JIMD_Editors: Another article from 2017’s January guideline bonanza: #openaccess Guidelines for diagnosis and management of the cobalam…
Another article from 2017’s January guideline bonanza: #openaccess Guidelines for diagnosis and management of the cobalamin‐related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency M Huemer et al, 2017 https://t.co/rhuu0ywe1
RT @HCUAmerica: #HCUAwareness2019 #HCUFact 23: The treatment #Guidelines for #MTHFR are: Betaine, folonic acid or methylfolate and/or L-#M…
RT @HCUAmerica: #HCUAwareness2019 #HCUFact 23: The treatment #Guidelines for #MTHFR are: Betaine, folonic acid or methylfolate and/or L-#M…
RT @HCUAmerica: #HCUAwareness2019 #HCUFact 23: The treatment #Guidelines for #MTHFR are: Betaine, folonic acid or methylfolate and/or L-#M…
#HCUAwareness2019 #HCUFact 23: The treatment #Guidelines for #MTHFR are: Betaine, folonic acid or methylfolate and/or L-#Methionine. Here is the a link to the guidelines for diagnosis and treatment of Cobalamin and MTHFR.https://t.co/Z50jGNQ88Z
HCU Fact #19: Also in 2016, the Guidelines for diagnosis & management of the cobalamin-related remethylation disorders & MTHFR deficiency were published in the Journal of inherited Metabolic Disorders. Make sure your genetics team reviews them. Vi
@bhrw @Sylviagaragoski Het is interessant dat men hydroxocobalamine IM en methylcobalamine oraal met elkaar heeft vergeleken. Hoe zou het verder met de beide patiëntgroepen gaan w.b. methylering, op langere termijn, na deze experimentele 6 maanden? https:/
Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency https://t.co/hRHuu14uHX
Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and #MTHFR deficiency. J Inherit Metab Dis. 2017 Jan;40(1):21-48. doi: 10.1007/s10545-016-9991-4. Epub 2016 Nov 30.https://t.co/hkrC
RT @SJDbarcelona_es: RT @Biblioteca_SJD: Guidelines for diagnosis and management of the cobalamin-related remeth... https://t.co/20zAp4bP3r…
RT @Biblioteca_SJD: Guidelines for diagnosis and management of the cobalamin-related remeth... https://t.co/5s4tkhee1L #PublicaSJDBarcelona
RT @Biblioteca_SJD: Guidelines for diagnosis and management of the cobalamin-related remeth... https://t.co/fI0JQcQu1s #PublicaSJDBarcelona
RT @Biblioteca_SJD: Guidelines for diagnosis and management of the cobalamin-related remeth... https://t.co/20zAp4bP3r #PublicaSJDBarcelona
Guidelines for diagnosis and management of the cobalamin-related remethyl... https://t.co/FZSnaWHcdg #PublicaSJDBarcelona @SJDbarcelona_es